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Objective  To compare the rate of restenosis between a cardiac rehabilitation (CR) group and a control group 
within three diff  erent generations of drug eluting stents (DES).
Method  Patients who received DES due to an acute coronary syndrome were included. Th   ey were divided into a 
CR group and a control group. Th   e CR group received six to eight weeks of early cardiac rehabilitation program in 
a hospital setting, and sustained a self-exercise program for six months in a community. Th   e control group was 
instructed to exercise by themselves after leaving the hospital. Nine months after the first onset of disease, we 
implemented a coronary angiography and compared the two groups. In addition, we divided the patients into 
three subgroups according to the generation of DES, and compared the rate of restenosis between the CR group 
and control group within these three subgroups.
Results  At 9 months, in-stent restenosis, measured as an in-segment late luminal loss (LLL) of the stented 
coronary area, was smaller in the CR group (n=52) 0.16±0.42 mm compared to the control group (n=51) 0.39±0.78 
mm (p<0.05). A reduction of LLL in the CR group compared to the control group was consistent among the three 
diff  erent generations of DES.
Conclusion  The CR program is strongly associated with a significant reduction in LLL in the stented coronary 
segments, regardless of the generation of DES.
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INTRODUCTION
Regular exercise is known to be eff  ective for the primary 
and secondary preventions of cardiovascular disease.
1,2 
Studies have reported that a systematic cardiac rehabili-
tation combined with regular exercise improved cardio-
pulmonary function, psychosocial state, and quality of 
life of the patient, decreased the all-cause and cardiovas-
cular mortality by 20-30%,
3-5 and delayed the progression 
or reduced the severity of artherosclerosis.
6,7 Primary 
percutaneous coronary intervention (PCI) was effective 
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for long- and short-term treatment of patients with acute 
myocardial infarction,
8 though considerable recurrence 
and restenosis were reported.
9 Although the rate of stent 
thrombosis occurrence within 12 months after PCI was 
reported to be approximately 1% because of a new dual-
antiplatelet therapy regimen, the mortality due to stent 
thrombosis was 20-40%.
1 As such, to reduce the inci-
dence of restenosis in the stented coronary area, a drug-
eluting stent (DES) was introduced, and studies have 
reported that the rate of restenosis was signifi  cantly lower 
in the DES group than in the bare metal stent group.
10,11 
In the DES, however, late stent thrombosis occurred 1-12 
months after the intervention due to delayed strut endo-
thelialization and potential prothrombotic characteris-
tics.
1 Th   us, safety continues to be a problem.
12
Coronary sclerosis and its risk factors interrupt the 
vasolidation produced by the vascular endothelial cells, 
and change the relationship between the vascular wall, 
infl  ammatory cells, and platelets.
13 Th   e growth of tunica 
intima is related to the late luminal loss after the implan-
tation of the stent,
14 and with the inflammatory reac-
tion caused by persistent shear stress
15 and the vascular 
damage that accompanies increased c-reactive protein 
(CRP).
16 Th   e endothelial dysfunction that occurs after the 
implantation of the stent is an independent predictor of 
initial restenosis.
17
Based on these findings, studies have revealed that 6 
months of regular exercise after the insertion of the stent 
reduced the late luminal loss in the stented area.
18 In ad-
dition, an increased peak VO2 could improve exercise 
capability and regular exercise improved endothelium-
dependent vasodilatation through the activation of endo-
thelial nitric oxide synthase.
18 In another study examin-
ing patients with stable coronary artery stenosis (≤75% 
diameter stenosis), regular exercise without coronary 
artery intervention increased the maximum oxygen con-
sumption (VO2max) and thus, reduced the infl  ammatory 
reaction. This is unlike coronary intervention without 
regular exercise. In the two-year follow-up period of the 
patients, there were fewer cardiac events in the regular-
exercise-without-coronary intervention group.
19 
It is known that in patients with coronary artery dis-
eases, the implantation of a DES reduces the rate of reste-
nosis, compared with the insertion of a bare metal stent. 
However, there have not been any controlled studies that 
compared the extent of restenosis after the implantation 
of the DES in the cardiac rehabilitation group and in the 
non-cardiac rehabilitation group. Th   ere are also no pub-
lished studies that have compared the extent of the reste-
nosis of diff  erent types of DESs based on the fi  ndings that 
cardiac rehabilitation reduced the rate of restenosis after 
the insertion of a stent. As such, this study compared the 
extents of the in-stent restenosis between the cardiac re-
habilitation group and the control group of patients who 
had received various types of DESs.
MATERIALS AND METHODS
Subjects
Patients who were admitted to this hospital for acute 
coronary syndrome (ACS) and successfully underwent 
percutaneous coronary intervention (PCI) using a DES 
were included in this study. Th   e criterion for a successful 
PCI was a <30% reduction in residual diameter stenosis.
20 
Patients with a history of cardiovascular disease, cerebro-
vascular disease, or neuromusculoskeletal disease that 
may disturb the exercise program were excluded from 
this study. All subjects were asked to participate in the 
cardiac rehabilitation program through training on the 
need for cardiac rehabilitation and the contents of the 
program. The patients who wanted to participate in the 
cardiac rehabilitation program in a hospital setting were 
assigned to the cardiac rehabilitation group, and those 
who did not want to participate in the program, to the 
control group. Previous studies performed by this author 
have shown that the most common cause of non-partici-
pation in the cardiac rehabilitation program was a lack of 
awareness (78%), followed by doubt regarding the eff  ect 
of the program, lack of time, anxiety, prohibitive program 
cost, diffi   culty in movement, distance from the patient’s 
home to the hospital, and transportation difficulty. In 
particular, the causes of discontinuance of the cardiac 
rehabilitation program were a lack of awareness and the 
regional and socioeconomic conditions of the patient.
21
Methods
The patients in the cardiac rehabilitation group un-
derwent a pretest that included an exercise stress test at 
the cardiac rehabilitation clinic of our hospital after they 
were discharged following a coronary artery intervention. 
On average, they began performing cardiac rehabilitation 
exercise 14 days after the onset of the disease.
For the exercise stress test, the symptom-limited exer-
cise test based on the modifi  ed Bruce protocol was used. Chul Kim, et al.
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Based on the maximum and resting heart rates that were 
measured in the exercise stress test, the heart rate reserve 
was calculated, and the exercise intensity was set at the 
target heart rate (40-85% of the heart rate reserve). The 
objective markers that included the electrocardiographic 
change, heart rate, and blood pressure (BP) were moni-
tored, and the patient’s subjective symptoms during the 
exercise were monitored based on Borg’s rate of per-
ceived exertion (RPE), a subjective marker. Each training 
session comprised a warm-up (10 min), main exercise 
(30 min), and cool-down (10 min). Th   e main exercise in-
cluded a treadmill course (8 min), rest (3 min), ergometer 
measurement (8 min), rest (3 min), and another tread-
mill course (8 min). Th   e patients were asked to perform 
the 50-min exercise program three times a week for 6-8 
weeks (for a total of 18-24 sessions), and all the patients 
and their families were educated on the risk factors, drug 
therapy, and smoking cessation, and given obesity and 
nutrition consultations. A blood test, body mass index 
measurement, BP measurement, and exercise consulta-
tion were performed at one- to three-month intervals 
to ensure that the patients managed their risk factors of 
coronary artery disease. After 6-8 weeks of the in-hospital 
exercise program, an exercise stress test was performed 
to determine the target heart rate and the RPE, based on 
which another new exercise was prescribed and the pa-
tients were asked to continue doing the newly prescribed 
exercise in a community setting for up to nine months af-
ter the onset of the disease. Th   e control group that did not 
participate in the cardiac rehabilitation program received 
basic training on the management of risk factors after the 
onset of the acute coronary artery syndrome risk factors 
and on exercising; and the patients were left to carry out 
the risk factor management and exercises on their own.
The patients in the cardiac rehabilitation and control 
groups were followed and all received a drug prescription 
for up to nine months at the cardiac medicine and reha-
bilitation clinics as outpatients. Both groups underwent 
coronary angiography with the same cardiologist both at 
the time of their initial PCI and nine months after the on-
set of the disease. Based on the groups’ minimal lumen 
diameter (MLD), their diameter stenosis % was mea-
sured, and their late luminal loss (LLL) and luminal loss 
(LL %) at the time of the onset of the disease and at nine 
months were compared. Th   e criterion for restenosis was 
>50% of the in-stent diameter stenosis.
22 Next, the pa-
tients were further divided into the fi  rst-generation stent 
group (Taxus and Cypher), the second-generation stent 
group (Endeavor Sprint and Endeavor Resolute), and the 
third-generation stent group (Xience and Promus), and 
their in-stent diameter stenosis values were compared 
using the same markers as those between the three sub-
groups in the cardiac rehabilitation and control groups.
Statistical analysis
For statistical analysis, the SAS Enterprise Guide 4.1 
(4.1.0.471) was used. A Wilcoxon rank sum test was used 
to compare the cardiac rehabilitation and control groups 
in terms of their sexes, ages, ST segment elevation myo-
cardial infarctions, non-ST segment elevation myocardial 
infarctions, proportions of patients with unstable angina, 
hypertension, diabetes, numbers of cases of dyslipid-
emia, smoking habits, body mass indexes, left ventricu-
lar ejection fractions (LVEF) at the start of their cardiac 
rehabilitation, and drug used, as well as their HbA1c 
values at the start of and nine months after their cardiac 
rehabilitation. Th   e Wilcoxon rank sum test was also used 
to compare the number and locations of the affected 
vessels, number of stents used, and number of stents in 
each generation (further classifi  ed according to the types 
of DES) in the cardiac rehabilitation and control groups. 
Th   e response values were ranked using a Wilcoxon rank 
sum test, which involved multiple comparisons of the re-
sults of the Kruskal-Wallis test. Th   e rankings were applied 
to a one-way ANOVA multiple comparison to compare 
the diameter stenoses with the three types of stents.
RESULTS
Baseline characteristics of the subjects
A total of 103 patients were included in this study, and 
they were classifi  ed into the cardiac rehabilitation group 
(n=52) and the control group (n=51). Th   ere was no diff  er-
ence in the sex ratios between the cardiac rehabilitation 
group (male=35 and female=17) and the control group 
(male=41 and female=10).
The mean age did not significantly differ between the 
groups: 61.08 years in the cardiac rehabilitation group 
and 64 years in the control group. The numbers of pa-
tients with acute coronary syndromes classified into 
ST-elevation myocardial infarction, non-ST-elevation 
myocardial infarction, and unstable angina did not diff  er Cardiac Rehabilitation on In-stent Restenosis
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between the two groups.
The numbers and locations of the affected vessels did 
not diff  er between the two groups. Th   e LVEF and risk fac-
tors (hypertension, diabetes, hyperlipidemia, smoking 
history, and body mass index) at the start of the cardiac 
rehabilitation and the types of drugs given did not dif-
fer between the two groups. Fifty-four stents were used 
in the cardiac rehabilitation group and 51 in the control 
group. The number of first-generation (Taxus and Ci-
pher), second-generation (Endeavor Sprint, Coroflex, 
and Pico Elite), and third-generation (Endeavor Resolute, 
Promus, and Xince V) stents that were used did not diff  er 
between the two groups (Tables 1, 2).
Comparison of the in-stent restenoses of the cardiac 
rehabilitation group and the control group nine 
months after their coronary artery intervention
Nine months after the coronary artery intervention, the 
coronary angiography did not reveal a signifi  cant diff  er-
ence in the minimal luminal diameters between the two 
groups. However, there was a signifi  cant diff  erence in the 
late luminal losses between the two groups (0.16±0.42 
mm in the cardiac rehabilitation group and 0.39±0.78 
mm in the control group) and a signifi  cant diff  erence in 
the late losses between the two groups (1.2±19.5% in the 
cardiac rehabilitation group and 13.2±25.5% in the con-
trol group) (p=0.002).
Th   e residual diameter stenosis (%DS), an indication of 
the extent of the restenosis, was lower in the cardiac re-
habilitation group (12.5±19.5%) than in the control group 
(13.2±25.5%), though the difference was not significant 
(Table 3).
Comparison of the in-stent restenosis with other factors
Nine-month follow-up data revealed after the coronary 
artery intervention, the number of patients with in-stent 
restenosis did not significantly differ between the reha-
bilitation group (n=1, 1.9%) and the control group (n=8, 
15.7%). After the onset of the disease, the LVEF was high-
Table 1. Characteristics of Subjects
CR 
(n=52)
Control 
(n=51)
p-value
Male/Female 35/17 41/10 0.13
Age (year) 61.08 64 0.12
Diagnosis (STEMI/
NSTEMI/UA)
18/10/24 16/10/25 0.84
Hypertension 32 (61.5%) 30 (58.8%) 0.78
Diabetes 10 (19.2%) 18 (35.3%) 0.07
Hyperlipidemia 42 (80.8%) 34 (67%) 0.10
Smoking (Current/Ex/
Never)
23/9/20 28/13/10 0.10
BMI 24.55 24.86 0.96
LVEF (%) 58.25 57.8 0.79
Acetylsalicylic acid 52 49 0.15
Clopidogrel 52 51 1.00
Beta blocker 32 22 0.90
ACEI/ARB 36 35 0.95
Statin 50 48 0.63
CR: Cardiac rehabilitation, STEMI: ST elevation myocar-
dial infarction, NSTEMI: Non-ST elevation myocardial 
infarction, UA: Unstable angina, BMI: Body mass index, 
LVEF: Left ventricular ejection fraction, ACEI: Angioten-
sin-1 conversion enzyme inhibitor, ARB: Angiotensin-2 
receptor blocker 
Table 2. Angiographic and Procedural Characteristics
CR (n=52) Control (n=51) p-value
Number of diseased vessels 0.43
   1/2/3  32/16/4 38/8/5
Target vessel artery 0.13
   LAD/LCX/RCA  39/2/11 29/6/16
Number of stents  54 51 0.22
DES type   0.74
   1
st generation (Taxus/Cypher) 16 (9/7) 22 (14/8)
   2
nd generation (Endeavor sprinter/Corofl  ex/Pico elite)  25 (20/4/1) 13 (7/2/4)
   3
rd generation (Endeavor resolute/Promus/Xince V)  13 (4/3/6) 16 (11/2/3)
CR: Cardiac rehabilitation, LAD: Left anterior descending, LCX: Left circumflex, RCA: Right coronary artery, DES: 
Drug eluting stentChul Kim, et al.
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er in the cardiac rehabilitation group than in the control 
group, and the HbA1c level, a marker of diabetes control, 
was lower in the cardiac rehabilitation group, though in 
both cases, they were not signifi  cant (p<0.063) (Table 4).
Comparison of restenoses based on different genera-
tions of DESs
The numbers of first-, second-, and third-generation 
stents that were used in the cardiac rehabilitation group 
were 16, 25, and 13, respectively, and in the control 
group, 22, 13, and 16, respectively.
In the cardiac rehabilitation group that performed the 
rehabilitation for nine months and in the control group, 
there was no diff  erence in the diameter restenoses of the 
three subgroups that received the three diff  erent types of 
DESs (Table 5).
DISCUSSION
Although advances in medical technology have gradu-
ally reduced mortality due to coronary artery disease, the 
prevalence of the disease continues to rise each year.
23,24 
It was reported that for patients who had survived, par-
ticularly those who had experienced myocardial infarc-
tion, their quality of life would decrease due to their 
decreased ability to be active in daily life.
25 As hospital 
stay has shortened due to advances in coronary artery 
intervention and the development of novel drugs,
26 the 
need to control possible complications and risk factors of 
recurrence has emerged.
Cardiac rehabilitation is considered particularly im-
portant because it is known to improve the exercise ca-
pability of patients with coronary artery disease and in 
the secondary prevention of the disease through a com-
prehensive program that consists of an individualized 
exercise program based on the exercise prescription, nu-
trition consultation, a smoking cessation program, drug 
therapy, and weight control.
27
Post-coronary artery intervention restenosis has a high 
medical cost and an increased risk of revascularization.
18 
Both the bare metal stent and the DES have the possible 
issue of stent thrombosis and restenosis, and thus, may 
result in the recurrence of myocardial infarction and 
death.
28 In particular, it was reported that a DES could 
result in hypersensitivity to polymers and delayed endo-
thelialization in the stented area,
28 and that DM, among 
the predictors of thrombosis, decreased the eff  ect of an-
tiplatelet agents, such as aspirin and clopidogrel.
29 In this 
study, of the eight patients with restenosis in the control 
group, three had DM. In addition, a study had reported 
that regular exercise reduced the infl  ammatory reaction 
related to the in-stent restenosis in patients with heart 
failure or CAD.
18 Th   us, it is believed that various relevant 
factors that may induce restenosis should be controlled 
with an active cardiac rehabilitation program for patients 
Table 3. QCA Results at 9 Months
CR (n=52) Control (n=51) p-value
Lesion length (mm) 19.5±6.1 20.8±6.4 0.25
Reference diameter (mm) 2.7±0.5 2.8±0.5 0.63
Minimal luminal diameter (mm) 2.3±0.5 2.1±0.7 0.13
Late luminal loss (mm) 0.16±0.42 0.39±0.78 0.013
Residual diameter stenosis (%DS)
Before PCI 92.9±6.6 90.4±9.4 0.21
Immediately after PCI 11.4±13.8 8.5±15.3 0.28
9 months after PCI 12.5±21.3 21.9±23.2 0.052
Late loss (%) 1.2±19.5 13.2±25.5 0.002
QCA: Quantitative coronary angiography, CR: Cardiac rehabilitation, PCI: Percutaneous coronary intervention
Table 4. In-Stent Restenosis and Other Features at 9 
Months
CR Group 
(n=52)
Control 
(n=51)
p-value
Number of ISR 1 8 0.014
Rate of restenosis (%) 1.9 15.7
LVEF at entry 58.24±10.19 57.80±10.28 0.79
LVEF at 9 months 64.29±14.15 59.85±11.46 0.07
CR: Cardiac rehabilitation, ISR: In-stent restenosis, LVEF: 
Left ventricular ejection fractionCardiac Rehabilitation on In-stent Restenosis
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who had undergone coronary artery intervention. This 
study was performed with patients who had a DES im-
planted, and we investigated the infl  uence of cardiac re-
habilitation-based regular exercise on post-stent implan-
tation restenosis in patients who had a DES implant. A 
study that compared two types of fi  rst-generation DESs, a 
SES (sirolimus-eluting stent) and a PES (paclitaxel-eluting 
stent), showed that SES was superior to PES in reducing 
late loss
10 and another study reported that there was no 
diff  erence between SES and PES with regard to late loss.
26 
Th   is study compared the late restenoses of fi  rst-, second-, 
and third-generation stents, and found no diff  erence in 
the restenoses of the three generations in the cardiac re-
habilitation and control groups.
Recently, however, it was reported that the risk of very 
late thrombosis increased by 0.1-0.6% each year in the 
DES-implanted group (unlike in the bare-metal-stent-
implanted group)
30 and that interest in DES-related 
mortality and late stent thrombosis is increasing.
26,30 As 
such, studies are underway to compare mortality and the 
recurrence of myocardial infarction in relation to DES. 
Th   erefore, a study that compares the diameter restenoses 
after a short- and long-term follow-up is needed. One 
study that has demonstrated the relationship between a 
high level of activity and the proportion of cardiovascular 
diseases has shown that 3-6 months of high-intensity ex-
ercise reduced in-stent restenosis in patients who had un-
dergone coronary artery intervention. Th  e  high-intensity 
exercise was related to the activation of nitric oxide (NO) 
synthase (due to the improved vascular endothelial cells), 
the decreased CRP that promotes arteriosclerosis, and 
the reduced endothelin-1 production that exacerbates 
the endothelial cell function.
18 Likewise, in this study, late 
luminal loss and late loss were signifi  cantly lower in the 
cardiac rehabilitation group than in the control group, 
and the number of patients with in-stent restenosis sig-
nificantly differed between the two groups (n=1 and 8, 
respectively). Steady cardiac rehabilitation-based exer-
cise capability measurement can assist in the early detec-
tion of coronary artery restenosis
31 and the assessment of 
the exercise capability through regular measurement of 
the VO2 consumption can be the most robust and inde-
pendent predictor of cardiovascular disease mortality.
18 
Th   us, regular cardiac rehabilitation and exercise capabil-
ity measurements are considered important for patients 
who had undergone coronary artery intervention. The 
limitations of this study are: fi  rst, the decision to partici-
pate in the cardiac rehabilitation program was left to the 
patients to decide, and those with a high risk of cardiac 
crisis were not assigned to the community setting exer-
cise group. Th   us, it was impossible to perform a random 
selection comparative analysis. Second, the diff  erence in 
the management of various risk factors, such as hyper-
tension, diabetes, hyperlipidemia, obesity, and smoking 
between the two groups was not clearly identifi  ed. Th  ird, 
as the study period was nine months, follow-up time was 
short. Further studies with long-term comparison of the 
restenosis of the cardiac rehabilitation group with that of 
the control group and between diff  erent-generation DESs 
are needed, as are studies on the mortality and morbidity 
of coronary artery disease. Fourth, this study did not have 
a large sample, which was also a limitation in the other 
Table 5. QCA Results According to DES Type at 9 Months
CR (n=52) Control (n=51)
1
st G (n=16) 2
nd G (n=25) 3
rd G (n=13) 1
st G (n=22) 2
nd G (n=13) 3
rd G (n=16)
LL (mm) 21.3±7.2 17.2±4.5 20.0±5.6 22.2±6.9 21.8±5.6 17.7±5.6
RD (mm) 2.8±0.5 2.8±0.5 2.6±0.5 2.7±0.3 2.9±0.7 2.9±0.6
MLD (mm) 2.4±0.4 2.4±0.4 2.3±0.4 2.0±0.7 2.2±0.7 2.2±0.6
% DS
Before PCI 91.3±8.9 94.7±4.7 92.0±7.5 92.1±9.6 88.5±9.4 89.9±9.5
After PCI 13.1±11.1 13.1±11.1 9.9±13.1 7.8±14.1 9.3±17.2 8.9±16.1
9 months 11.5±23.7 11.5±23.7 13.4±11.3 24.5±23.7 19.2±26.2 21.0±28.7
LL (%) -1.6±22.6 -2.2±15.3 3.5±11.1 16.6±26.3 9.9±22.5 12.0±28.7
CR: Cardiac rehabilitation, QCA: Quantitative coronary angiography, DES: Drug eluting stent, G: Generation, LL: 
Lesion length, RD: Residual diameter, MLD: Minimal luminal diameter, DS: Diameter stenosis, PCI: Percutaneous 
coronary intervention, LL (%): Late lossChul Kim, et al.
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studies that compared restenosis after the insertion of 
DESs. In particular, interpreting the results of the studies 
that compared the diameter restenosis of different gen-
erations of DESs is still debatable. Th   us, it is believed that 
randomized controlled studies with more subjects will 
achieve more objective outcomes.
CONCLUSION
Cardiac rehabilitation significantly reduced in-stent 
late luminal loss, late loss, and percent diameter stenosis, 
regardless of the type of the ever-advancing DESs. This 
indicates that cardiac rehabilitation can signifi  cantly de-
lay the progression of in-stent restenosis.
Therefore, we expect that adequate exercise through 
cardiac rehabilitation can reduce the rate of intervention 
repetition and mortality in patients with cardiovascular 
disease or who had undergone a coronary artery inter-
vention.
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